Check Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Check Cap Ltd (CHEK) - Net Assets
Latest net assets as of June 2025: $-1.45 Million USD
Based on the latest financial reports, Check Cap Ltd (CHEK) has net assets worth $-1.45 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($377.00K) and total liabilities ($1.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.45 Million |
| % of Total Assets | -384.62% |
| Annual Growth Rate | N/A |
| 5-Year Change | -102.86% |
| 10-Year Change | -113.93% |
| Growth Volatility | 157.04 |
Check Cap Ltd - Net Assets Trend (2012–2025)
This chart illustrates how Check Cap Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Check Cap Ltd (2012–2025)
The table below shows the annual net assets of Check Cap Ltd from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-1.45 Million | 0.00% |
| 2024-12-31 | $-1.45 Million | -106.12% |
| 2023-12-31 | $23.69 Million | -42.66% |
| 2022-12-31 | $41.31 Million | -18.50% |
| 2021-12-31 | $50.69 Million | +209.51% |
| 2020-12-31 | $16.38 Million | +162.72% |
| 2019-12-31 | $6.23 Million | -52.16% |
| 2018-12-31 | $13.03 Million | +120.66% |
| 2017-12-31 | $5.91 Million | -43.26% |
| 2016-12-31 | $10.41 Million | -17.72% |
| 2015-12-31 | $12.65 Million | +467.94% |
| 2014-12-31 | $2.23 Million | +86.99% |
| 2013-12-31 | $1.19 Million | -76.78% |
| 2012-12-31 | $5.13 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Check Cap Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 15152000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $83.75 Million | % |
| Other Components | $84.81 Million | % |
| Total Equity | $-1.45 Million | 100.00% |
Check Cap Ltd Competitors by Market Cap
The table below lists competitors of Check Cap Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Express Transindo Utama Tbk
JK:TAXI
|
$9.43 Million |
|
ZOO DIGITAL GRP LS -01
F:2ZD
|
$9.43 Million |
|
Leviathan Gold Ltd
OTCQB:LVXFF
|
$9.43 Million |
|
BLACKROCK
BE:BLQA
|
$9.43 Million |
|
Almondz Global Securities Limited
NSE:ALMONDZ
|
$9.42 Million |
|
DigiCAP Co. Ltd
KQ:197140
|
$9.42 Million |
|
Holand og Setskog Sparebank
OL:HSPG
|
$9.42 Million |
|
PATERSON RESOURCES LTD
F:U40
|
$9.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Check Cap Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -1,450,000 to -1,450,000, a change of 0.
- Net loss of 25,149,000 reduced equity.
- Other factors increased equity by 25,149,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-25.15 Million | -1734.41% |
| Other Changes | $25.15 Million | +1734.41% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Check Cap Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $206.33 | $139.00 | x |
| 2013-12-31 | $47.91 | $139.00 | x |
| 2014-12-31 | $44.86 | $139.00 | x |
| 2015-12-31 | $254.70 | $139.00 | x |
| 2016-12-31 | $172.27 | $139.00 | x |
| 2017-12-31 | $81.17 | $139.00 | x |
| 2018-12-31 | $64.22 | $139.00 | x |
| 2019-12-31 | $15.61 | $139.00 | x |
| 2020-12-31 | $10.79 | $139.00 | x |
| 2021-12-31 | $12.24 | $139.00 | x |
| 2022-12-31 | $7.28 | $139.00 | x |
| 2023-12-31 | $4.05 | $139.00 | x |
| 2024-12-31 | $-0.25 | $139.00 | x |
| 2025-12-31 | $-0.25 | $139.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Check Cap Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-105.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -72.55% | 0.00% | 0.00x | 1.66x | $-4.23 Million |
| 2013 | -335.43% | 0.00% | 0.00x | 4.51x | $-4.11 Million |
| 2014 | -183.03% | 0.00% | -0.10x | 3.50x | $-4.30 Million |
| 2015 | -97.17% | -7104.05% | 0.01x | 1.21x | $-13.55 Million |
| 2016 | -84.81% | -3617.21% | 0.02x | 1.18x | $-9.87 Million |
| 2017 | -165.47% | 0.00% | 0.00x | 1.34x | $-10.36 Million |
| 2018 | -81.27% | 0.00% | 0.00x | 1.18x | $-11.89 Million |
| 2019 | -221.94% | 0.00% | 0.00x | 1.51x | $-14.46 Million |
| 2020 | -84.54% | 0.00% | 0.00x | 1.20x | $-15.48 Million |
| 2021 | -33.94% | 0.00% | 0.00x | 1.10x | $-22.27 Million |
| 2022 | -46.25% | 0.00% | 0.00x | 1.10x | $-23.24 Million |
| 2023 | -74.17% | 0.00% | 0.00x | 1.06x | $-19.94 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.00 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.00 Million |
Industry Comparison
This section compares Check Cap Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $867,957,363
- Average return on equity (ROE) among peers: -141.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Check Cap Ltd (CHEK) | $-1.45 Million | -72.55% | N/A | $9.42 Million |
| Agilent Technologies Inc (A) | $4.57 Billion | 6.91% | 0.87x | $31.45 Billion |
| Amer Bio Medica (ABMC) | $-944.00K | 0.00% | 0.00x | $3.55K |
| ADCNF (ADCNF) | $612.34 Million | 111.18% | 6.93x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.64 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $4.37 Million | -93.77% | 0.93x | $36.19K |
| Avricore Health Inc (AVCRF) | $3.35 Million | -65.62% | 0.06x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $4.67 Million | -153.12% | 0.85x | $664.47K |
| Biodesix Inc (BDSX) | $4.58 Million | -1138.56% | 20.64x | $48.86 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |